- Country: Czech Republic
- Summary: Selective Immunosuppressants - Ozanimod I.
- CZT Ref No: 111100486
- Deadline: 08 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CZK 5554000
- Notice Type: Tender
- Document Ref. No.: 739045-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the public contract is the supply of medicinal products for oral administration containing the active substance ozanimod (ATC L04AE02) for the treatment of patients in the approved indication of ulcerative colitis (UC) according to the SPC valid on the date of submission of tenders.
Selective immunosuppressants - Ozanimod I.
Doc Title: Selective - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSelective Immunosuppressants - Ozanimod I. - Czech Republic Tender
The INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE, a Government sector organization in Czech Republic, has announced a new tender for Selective Immunosuppressants - Ozanimod I.. This tender is published on CzechRepublicTenders under CZT Ref No: 111100486 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-08.
The estimated tender value is CZK 5554000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
